Petrobras Argentina S.A. (PZE) 6.24 $PZE Shares of PZE

New Post Public Reply Private Reply Replies (0) Message Board

Sep 5, 2016 at 3:19 PM

Petrobras Argentina S.A. (PZE) 6.24 $PZE

Shares of PZE Now Oversold
EnergyStockChannel.com - Wed May 04, 10:37AM CDT
In trading on Wednesday, shares of Petrobras Argentina SA entered into oversold territory, changing hands as low as $6.07 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator...
PZE: 6.24 (+0.04)

Capturing Market Movement in Equities - Research on Gerdau, Petrobras Argentina, Marchex and PCTEL
ACCESSWIRE - Thu Jan 28, 6:50AM CST
NEW YORK, NY / ACCESSWIRE / January 28, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Gerdau SA (NYSE: GGB), Petrobras Argentina SA (NYSE: PZE), Marchex Inc. (NASDAQ: MCHX) and PCTEL Inc. (NASDAQ: PCTI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
PCTI: 5.09 (+0.04), PZE: 6.24 (+0.04), GGB: 2.89 (+0.19), MCHX: 2.86 (+0.06)

Where We Are Headed - Featured Research on United Community Financial, Petrobras Argentina, Yanzhou Coal Mining, and Safe Bulkers
ACCESSWIRE - Wed Dec 23, 7:15AM CST
NEW YORK, NY / ACCESSWIRE / December 23, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: United Community Financial Corp (NASDAQ: UCFC), Petrobras Argentina SA (NYSE: PZE), Yanzhou Coal Mining Co Ltd (NYSE: YZC) and Safe Bulkers Inc. (NYSE: SB). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
YZC: 5.91 (+0.16), PZE: 6.24 (+0.04), UCFC: 6.63 (+0.03), SB: 1.31 (+0.01)

Petrobras Energia Participaciones Has Returned 26.7% Since SmarTrend Recommendation (PZE)
Comtex SmarTrend(R) - Fri Oct 23, 5:34PM CDT
SmarTrend identified a Downtrend for Petrobras Energia Participaciones (NYSE

ZE) on June 1st, 2015 at $6.87. In approximately 5 months, Petrobras Energia Participaciones has returned 26.73% as of today's recent price of $5.03.
PZE: 6.24 (+0.04)

Petrobras Energia Participaciones Down 18.9% Since SmarTrend Downtrend Call (PZE)
Comtex SmarTrend(R) - Wed Oct 07, 5:04PM CDT
SmarTrend identified a Downtrend for Petrobras Energia Participaciones (NYSE

ZE) on June 1st, 2015 at $6.87. In approximately 4 months, Petrobras Energia Participaciones has returned 18.86% as of today's recent price of $5.57.
PZE: 6.24 (+0.04)

Honeywell's Spectra Fiber Selected for Petrobras Project
Zacks Equity Research - Zacks Investment Research - Tue Oct 06, 9:40AM CDT
Honeywell International Inc (HON) recently announced the selection of its Spectra fiber for use in ropes for new offshore oil and gas platforms for Petrobras Argentina SA (PZE) - one of the largest oil and gas companies in Latin America.
PZE: 6.24 (+0.04), HON: 116.39 (+0.26), DHR: 81.19 (-0.25), SERV: 37.56 (unch)

Petrobras Energia Participaciones Down 26.3% Since SmarTrend Downtrend Call (PZE)
Comtex SmarTrend(R) - Wed Sep 30, 11:47AM CDT
SmarTrend identified a Downtrend for Petrobras Energia Participaciones (NYSE

ZE) on June 1st, 2015 at $6.87. In approximately 4 months, Petrobras Energia Participaciones has returned 26.29% as of today's recent price of $5.06.
PZE: 6.24 (+0.04)

Moving Average Crossover Alert: Petrobras Argentina (PZE)
Zacks Equity Research - Zacks Investment Research - Thu Sep 24, 7:43AM CDT
Moving Average Crossover Alert: Petrobras Argentina (PZE)
PZE: 6.24 (+0.04)

PZE Stock Crowded With Sellers
EnergyStockChannel.com - Wed Sep 23, 2:53PM CDT
In trading on Wednesday, shares of Petrobras Argentina SA entered into oversold territory, changing hands as low as $5.08 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator...
PZE: 6.24 (+0.04)

Petrobras Energia Participaciones Shares Down 21.0% Since SmarTrend's Sell Call (PZE)
Comtex SmarTrend(R) - Wed Sep 23, 10:40AM CDT
SmarTrend identified a Downtrend for Petrobras Energia Participaciones (NYSE

ZE) on June 1st, 2015 at $6.87. In approximately 4 months, Petrobras Energia Participaciones has returned 21.05% as of today's recent price of $5.42.
PZE: 6.24 (+0.04)

Downgrade Alert for Petrobras Energia Participaciones (PZE)
Comtex SmarTrend(R) - Thu Jul 02, 7:10AM CDT
Petrobras Energia Participaciones (NYSE

ZE) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $6.55 on volume of 96,000 shares, above average daily volume of 94,000. There is potential upside of 14.5% for shares of Petrobras Energia Participaciones based on a current price of $6.55 and an average consensus analyst price target of $7.50. The stock should find resistance at its 50-day moving average (MA) of $7.09, as well as support at its 200-day MA of $6.22.
PZE: 6.24 (+0.04)

Shares of PZE Up 36.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed May 27, 9:24AM CDT
SmarTrend identified an Uptrend for Petrobras Energia Participaciones (NYSE

ZE) on February 3rd, 2015 at $5.13. In approximately 4 months, Petrobras Energia Participaciones has returned 36.65% as of today's recent price of $7.01.
PZE: 6.24 (+0.04)

Uptrend Call Working As Petrobras Energia Participaciones Stock Rises 41.7% (PZE)
Comtex SmarTrend(R) - Tue May 19, 5:30PM CDT
SmarTrend identified an Uptrend for Petrobras Energia Participaciones (NYSE

ZE) on February 3rd, 2015 at $5.13. In approximately 4 months, Petrobras Energia Participaciones has returned 41.72% as of today's recent price of $7.27.
PZE: 6.24 (+0.04)

40.5% Return Seen to Date on SmarTrend Petrobras Energia Participaciones Call (PZE)
Comtex SmarTrend(R) - Tue May 12, 11:22AM CDT
SmarTrend identified an Uptrend for Petrobras Energia Participaciones (NYSE

ZE) on February 3rd, 2015 at $5.13. In approximately 3 months, Petrobras Energia Participaciones has returned 40.55% as of today's recent price of $7.21.
PZE: 6.24 (+0.04)

Petrobras Energia Participaciones Shares Up 41.9% Since SmarTrend's Buy Recommendation (PZE)
Comtex SmarTrend(R) - Tue May 05, 10:06AM CDT
SmarTrend identified an Uptrend for Petrobras Energia Participaciones (NYSE

ZE) on February 3rd, 2015 at $5.13. In approximately 3 months, Petrobras Energia Participaciones has returned 41.91% as of today's recent price of $7.28.
PZE: 6.24 (+0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

CVS Study: GLP-1 Drugs Effective But Costly

By Hannah Lewis Updated Nov 15, 2026 Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

IDEAYA's IDE101: A New Front in Cancer Battle

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Berry Street Integrates AI with What Matters: Human Touch

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Investors Gear Up for Lennar Class Action Lawsuit

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...